We are live on ! Find out more
STRO icon

Sutro Biopharma

134 hedge funds and large institutions have $819M invested in Sutro Biopharma in 2020 Q4 according to their latest regulatory filings, with 61 funds opening new positions, 45 increasing their positions, 18 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

369% more first-time investments, than exits

New positions opened: 61 | Existing positions closed: 13

200% more funds holding in top 10

Funds holding in top 10: 26 (+4)

169% more capital invested

Capital invested by funds: $304M → $819M (+$515M)

150% more repeat investments, than reductions

Existing positions increased: 45 | Existing positions reduced: 18

96% more call options, than puts

Call options by funds: $1.5M | Put options by funds: $763K

56% more funds holding

Funds holding: 86134 (+48)

0.14% more ownership

Funds ownership: 8.51%8.66% (+0.14%)

Holders
134
Holders Change
+48
Holders Change %
+55.81%
% of All Funds
2.37%
Holding in Top 10
6
Holding in Top 10 Change
+4
Holding in Top 10 Change %
+200%
% of All Funds
0.11%
New
61
Increased
45
Reduced
18
Closed
13
Calls
$1.5M
Puts
$763K
Net Calls
+$732K
Net Calls Change
+$732K
Name Holding Trade Value Shares
Change
Change in
Stake
California Public Employees Retirement System
76
California Public Employees Retirement System
California
$1.17M +$3.31K +20 +0.4%
Russell Investments Group
77
Russell Investments Group
United Kingdom
$1.11M +$386K +2,334 +84%
Citigroup
78
Citigroup
New York
$1.08M +$807K +4,872 +3,898%
Two Sigma Investments
79
Two Sigma Investments
New York
$1.06M -$975K -5,888 -55%
Two Sigma Advisers
80
Two Sigma Advisers
New York
$931K +$18.2K +110 +3%
California State Teachers Retirement System (CalSTRS)
81
California State Teachers Retirement System (CalSTRS)
California
$916K +$49K +296 +8%
State of Wisconsin Investment Board
82
State of Wisconsin Investment Board
Wisconsin
$791K +$154K +930 +34%
ECM
83
ExodusPoint Capital Management
New York
$789K +$602K +3,635 New
AC
84
Athanor Capital
New York
$679K +$518K +3,128 New
Renaissance Technologies
85
Renaissance Technologies
New York
$652K +$497K +3,001 New
CS
86
Credit Suisse
Switzerland
$625K +$477K +2,879 New
RhumbLine Advisers
87
RhumbLine Advisers
Massachusetts
$602K +$119K +720 +35%
New York State Common Retirement Fund
88
New York State Common Retirement Fund
New York
$510K +$207K +1,250 +114%
ACI
89
AMP Capital Investors
Australia
$476K +$361K +2,179 New
T. Rowe Price Associates
90
T. Rowe Price Associates
Maryland
$455K +$347K +2,097 New
JF
91
Jump Financial
Illinois
$449K +$343K +2,069 New
EGM
92
Engineers Gate Manager
New York
$423K +$323K +1,949 New
Manulife (Manufacturers Life Insurance)
93
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$374K +$40.7K +246 +17%
CSS
94
Cubist Systematic Strategies
Connecticut
$358K +$104K +627 +61%
AllianceBernstein
95
AllianceBernstein
Tennessee
$345K +$51.3K +310 +24%
AQR Capital Management
96
AQR Capital Management
Connecticut
$326K +$249K +1,501 New
VEA
97
Virtus ETF Advisers
New York
$295K +$225K +1,358 New
MIM
98
MetLife Investment Management
New Jersey
$273K
Nomura Holdings
99
Nomura Holdings
Japan
$272K -$811K -4,900 -80%
ProShare Advisors
100
ProShare Advisors
Maryland
$263K +$201K +1,214 New

STRO Hedge Fund Activity: Q4 2020 in Review

134 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in Sutro Biopharma (STRO) for Q4 2020, worth a combined $819M — up 169% from $304M a quarter earlier.

Buyers outnumbered sellers: 61 funds opened new STRO positions and 13 closed out — a net gain of 48 holders — while 45 added to existing stakes and 18 trimmed.

The largest buyer was Franklin Resources, opening a new position worth an estimated $36.9M. The largest seller was EcoR1 Capital, cutting an estimated $50M.

  • 134 institutional investors held Sutro Biopharma (STRO) as of Q4 2020, up from 86 in Q3 2020.
  • Funds reported $819M of Sutro Biopharma stock for Q4 2020, up 169% quarter-over-quarter.
  • 61 funds opened new Sutro Biopharma positions in Q4 2020 and 13 closed out, a net change of +48 holders.
  • The largest Sutro Biopharma buyer in Q4 2020 was Franklin Resources, an estimated $36.9M added.
  • The largest Sutro Biopharma seller in Q4 2020 was EcoR1 Capital, an estimated $50M sold.

Based on aggregated 13F filings for Q4 2020.